skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Stress echocardiogaphy: A useful test for assessing cardiac risk in diabetes

Review

(2731) Views  (691) Full article downloads

Authors: Rajan Sharma, Denis Pellerin

Published Date November 2008 Volume 2009:5 Pages 1 - 7
DOI: http://dx.doi.org/10.2147/VHRM.S3165

Rajan Sharma1, Denis Pellerin2

1Ealing Hospital, London, UK; 2The Heart Hospital, London, UK

Abstract: Cardiovascular disease is the leading cause of death in patients with diabetes therefore prompt diagnosis and treatment of high risk groups is essential. Dobutamine stress echocardiography is a safe, cheap and reliable method for coronary artery disease diagnosis and provides important long term prognostic information. The diagnostic accuracy and prognostic power of this technique has been validated by a number of studies on patients with and without diabetes. This article discusses the application, interpretation, and accuracy of stress echocardiography both in the general population and in patients with diabetes. The role of advanced imaging modalites such as myocardial contrast agents and tissue Doppler imaging is also explored.

Keywords: diabetes, dobutamine stress echocardiography, ischemia, cardiovascular risk








Readers of this article also read:

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Effects of efforts to intensify management on blood pressure control among patients with type 2 diabetes mellitus and hypertension: A pilot study
Berberine: metabolic and cardiovascular effects in preclinical and clinical trials
Early cardiovascular abnormalities in newly diagnosed obstructive sleep apnea
ABO and rhesus blood group distribution in Kurds
Anesthesiologists’ perception of patients’ anxiety under regional anesthesia
Nonsteroidal anti-inflammatory drug gastropathy: new avenues for safety
Patient considerations and clinical utility of a fixed dose combination of saxagliptin/metformin in the treatment of type 2 diabetes
Medical treatment and long-term outcome of chronic atrial fibrillation in the aged with chest distress: a retrospective analysis versus sinus rhythm
Cardiac ryanodine receptor in metabolic syndrome: is JTV519 (K201) future therapy?
  • Join ISVH

    Be part of the World's leading experts in vascular health by joining the International Society of Vascular Health (ISVH)

  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University